Weak pharma progress in Q2 sparks issues
Regardless of a strong efficiency by homegrown pharma corporations within the June quarter, pushed by improved progress within the US ...
Regardless of a strong efficiency by homegrown pharma corporations within the June quarter, pushed by improved progress within the US ...
After a superb run in monetary 12 months 2022, Divi’s Laboratories Ltd has two essential issues to grapple with. One, ...
NEW DELHI : The Nifty Pharma index has declined 4.65% within the yr as far as market volatility and uncooked ...
The Nifty Pharma index is underperforming the benchmark NSE Nifty index since September 2020 after the brand new regular. In ...
[mc4wp_form id=”158″]
© 2021 Success News - Developed by Sawah Web.
© 2021 Success News - Developed by Sawah Web.